ADRX

NASD ADARx Pharmaceuticals, Inc.

Oct 19, 2026 · 6:13 AM ET LAST TRADE Market Closed

$17.24 ↓ -0.41 (-2.32%) Trading Down from the previous close of $17.65

YTD change: -10.90%
vs 20-day SMA: N/A
vs 200-day SMA: N/A

Price ranges

Previous day

$17.50 $18.60

open $17.73 close $17.65

-$0.08 (-0.45%)

Today

$0.00 $0.00

$17.24

Past week

$17.31 $18.82

from $17.78 now $17.24

-$0.54 (-3.04%)

Past month

$0.00 $19.35

from $19.35 now $17.24

-$2.11 (-10.90%)

This year

$16.64 $23.21

from $19.35 now $17.24

-$2.11 (-10.90%)

Price & Performance

-1.70 (-8.79%) / 6M

Signals & Sentiment

Momentum, market sentiment, and recent alerts

N/A

The stock is 25.7% away from all-time highs of $23.21
ADRX is down 11% since the beginning of the year
ADRX is down 11% over the past 12 months
ADRX is down 11% over the past 1 month
3% of all ADRX investors are betting against ADRX

ADRX reads n/a: the 12-month move is -8.8%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No

EPS $-0.2412

Earnings momentum N/A Quarterly EPS growth

Quarterly change N/A

Valuation

P/E ratio N/A

Enterprise value $1.8B

Balance sheet & scale

IncomeN/A

Revenue$6.1M

Cash$427.3M

Debt$6.9K

Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD

Market cap $1.9B

ADARx Pharmaceuticals, Inc. is a late-clinical-stage biotechnology company. It focuses on developing next-generation small interfering RNA (siRNA) therapeutics for diseases with significant unmet medical needs. The company was founded by Zhen Li in December 2019 and is headquartered in San Diego, CA.

Competitor comparison

No peer group available for this symbol.

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.